SI (Shoulder Innovations) YoY EBITDA Growth: 46.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SI Shoulder Innovations Inc SI
12 GF Score
Price $20.32
! 3 Warning Signs
View Full Analysis

What is Shoulder Innovations YoY EBITDA Growth?

Shoulder Innovations SI -0.34% 12 YoY EBITDA Growth is 46.40% as of Jun. 2026. GuruFocus rates SI with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Shoulder Innovations's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 46.40%.

Shoulder Innovations's EBITDA per Share for the three months ended in Jun. 2026 was $-0.48.

Shoulder Innovations YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Shoulder Innovations's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shoulder Innovations YoY EBITDA Growth Chart

Shoulder Innovations Annual Data
Trend Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 -17.95 -614.88

Shoulder Innovations Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -443.98 -265.61 -159.42 -143.02 46.40
SI
12GF Score
Shoulder Innovations Inc SI
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shoulder Innovations YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Shoulder Innovations's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-4.275--0.598)/ | -0.598 |
=-614.88 %

Shoulder Innovations's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.484--0.903)/ | -0.903 |
=46.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 46.40% mean?
Shoulder Innovations (SI) has a YoY EBITDA Growth of 46.40% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Shoulder Innovations and its competitors.
Is Shoulder Innovations' YoY EBITDA Growth too high?
Shoulder Innovations' current YoY EBITDA Growth is 46.40%. Overall, Shoulder Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' YoY EBITDA Growth compare to MASS and PACB?
Shoulder Innovations' YoY EBITDA Growth of 46.40% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Shoulder Innovations and its competitors. Shoulder Innovations's current YoY EBITDA Growth is 46.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (SI) has a current YoY EBITDA Growth of 46.40%. The current YoY EBITDA Growth is 46.40%. Shoulder Innovations' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Shoulder Innovations (SI), the current YoY EBITDA Growth is 46.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shoulder Innovations Business Description

Other Exchanges VB3:Germany
Address 1535 Steele Avenue SW, Suite B, Grand Rapids, MI, USA, 49507
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
12GF Score

Get the complete analysis for SI

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.32
Price